WESCO INTERNATIONAL INC (WCC) earnings date, results and what the price requires
NYSE · SEC CIK 0000929008 · SEC filings checked Oct 16, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 30, 2026 | $6.67B | $209.0M | $4.23 | Filing |
| Mar 31, 2026 | Apr 30, 2026 | $6.08B | $153.8M | $3.11 | Filing |
| Dec 31, 2025 | Feb 10, 2026 | $6.07B | $159.8M | $3.33 | Filing |
| Sep 30, 2025 | Oct 30, 2025 | $6.20B | $187.5M | $3.79 | Filing |
| Jun 30, 2025 | Jul 31, 2025 | $5.90B | $174.5M | $3.83 | Filing |
| Mar 31, 2025 | May 1, 2025 | $5.34B | $118.4M | $2.10 | Filing |
| Dec 31, 2024 | Feb 11, 2025 | $5.50B | $165.4M | $3.01 | Filing |
| Sep 30, 2024 | Oct 31, 2024 | $5.49B | $204.3M | $3.81 | Filing |
What would WESCO INTERNATIONAL INC have to report for its valuation to change?
At $340.89, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 15.0% a year, to $29.14. On that path the next quarter needs diluted EPS near $4.36, against $3.79 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | 15.0% | 15.0% |
| EPS needed in final year | $29.14 | $29.14 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. WCC goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.